SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Trost M)
 

Search: WFRF:(Trost M) > (2020-2024) > Altered ceramide me...

Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders

Kurzawa-Akanbi, M. (author)
Tammireddy, S. (author)
Fabrik, Ivo (author)
Gothenburg University,Göteborgs universitet,Wallenberg Centre for Molecular and Translational Medicine
show more...
Doherty, M. K. (author)
Heap, R. (author)
Burmann, Björn Marcus, 1979 (author)
Gothenburg University,Göteborgs universitet,Wallenberg Centre for Molecular and Translational Medicine
Matečko-Burmann, Irena (author)
Gothenburg University,Göteborgs universitet,Wallenberg Centre for Molecular and Translational Medicine
Trost, M. (author)
Lucocq, J. M. (author)
Gherman, A. V. (author)
Fairfoul, G. (author)
Singh, P. (author)
Burte, F. (author)
Green, A. (author)
McKeith, I. G. (author)
Whitfield, P. D. (author)
Härtlova, Anetta (author)
Gothenburg University,Göteborgs universitet,Wallenberg Centre for Molecular and Translational Medicine
Morris, C. M. (author)
show less...
 (creator_code:org_t)
2021-09-13
2021
English.
In: Acta Neuropathologica. - : Springer Science and Business Media LLC. - 0001-6322 .- 1432-0533. ; 142, s. 961-984
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Mutations in glucocerebrosidase (GBA) are the most prevalent genetic risk factor for Lewy body disorders (LBD)-collectively Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Despite this genetic association, it remains unclear how GBA mutations increase susceptibility to develop LBD. We investigated relationships between LBD-specific glucocerebrosidase deficits, GBA-related pathways, and alpha-synuclein levels in brain tissue from LBD and controls, with and without GBA mutations. We show that LBD is characterised by altered sphingolipid metabolism with prominent elevation of ceramide species, regardless of GBA mutations. Since extracellular vesicles (EV) could be involved in LBD pathogenesis by spreading disease-linked lipids and proteins, we investigated EV derived from post-mortem cerebrospinal fluid (CSF) and brain tissue from GBA mutation carriers and non-carriers. EV purified from LBD CSF and frontal cortex were heavily loaded with ceramides and neurodegeneration-linked proteins including alpha-synuclein and tau. Our in vitro studies demonstrate that LBD EV constitute a "pathological package" capable of inducing aggregation of wild-type alpha-synuclein, mediated through a combination of alpha-synuclein-ceramide interaction and the presence of pathological forms of alpha-synuclein. Together, our findings indicate that abnormalities in ceramide metabolism are a feature of LBD, constituting a promising source of biomarkers, and that GBA mutations likely accelerate the pathological process occurring in sporadic LBD through endolysosomal deficiency.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Lewy body disorders
Glucocerebrosidase
Extracellular vesicles
Exosomes
Alpha-synuclein
Ceramide
n-terminal acetylation
parkinsons-disease
gaucher-disease
glucocerebrosidase mutations
endoplasmic-reticulum
lysosomal storage
dementia
aggregation
pathology
multicenter
Neurosciences & Neurology
Pathology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view